PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27633058-0	2016	Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel.	Docetaxel	118-127	cell division cycle 20	Mus musculus	13-18	
27633058-1	2016	The role of cell division cycle 20 (CDC20) was investigated in chemoresistance to decetaxel and the underlying mechanisms in metastatic castration-resistant prostate cancer (mCRPC).	decetaxel	82-91	cell division cycle 20	Mus musculus	36-41	
27633058-2	2016	MTT assays were performed to determine effects of siRNA-mediated CDC20 knockdown on cell proliferation and anticancer activity of docetaxel.	Docetaxel	130-139	cell division cycle 20	Mus musculus	65-70	
27633058-6	2016	Knockdown of CDC20 suppressed cell proliferation and enhanced anticancer effect of docetaxel with IC50 reducing from 0.358 to 0.188 microg/ml in PC3 cells and 0.307 to 0.162 microg/ml in DU145 cells (P<0.01).	Docetaxel	83-92	cell division cycle 20	Homo sapiens	13-18	
27633058-10	2016	Silencing of CDC20 may be a new strategy to improve chemosensitization to docetaxel in mCRPC.	Docetaxel	74-83	cell division cycle 20	Mus musculus	13-18